Latest Breaking News On - Eterna therapeutics - Page 1 : vimarsana.com

Lineage to Present at 2024 BIO International Convention

Lineage to Present at 2024 BIO International Convention
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
San-diego
California
San-diego-convention-center
American
Brianm-culley
Lineage-cell-therapeutics-inc
Eterna-therapeutics-inc
Roche-group
Genentech
Business-solutions

Comparing Eterna Therapeutics (NASDAQ:ERNA) and Adicet Bio (NASDAQ:ACET)

Adicet Bio (NASDAQ:ACET – Get Free Report) and Eterna Therapeutics (NASDAQ:ERNA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability. Insider and Institutional Ownership 83.9% of Adicet […]

Massachusetts
United-states
Boston
Cambridge
Cambridgeshire
United-kingdom
Adicet-bio
Eterna-therapeutics-inc
Adicet-bio-inc
Factor-bioscience
Get-free-report
Eterna-therapeutics

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims...

United-states
Miami
Florida
American
Marco-baptista
Michaela-kyle-devins
Jerod-hanna-nieder
Steven-kirshblum
Jack-allen
Joseph-pantginis
Richardg-fessler
Brianm-culley

ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q1 2024

ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Eterna-therapeutics
Place-earnings

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Israel
California
United-states
Jerusalem
Israel-general-
Canada
American
David-schull
Brianm-culley
Roche-group
Eterna-therapeutics-inc
Genentech

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases...

Israel
Jerusalem
Israel-general-
United-states
American
David-telander
Brianm-culley
Roche-group
Genentech
Foundation-fighting-blindness
Exchange-commission
Oregon-health-science-university-casey-eye-institute

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Award Will Support 2nd Annual Spinal Cord Injury Investor Symposium To Be Held June 26 and 27, 2024 ...

California
United-states
Miami
Florida
American
Jerod-hanna-nieder
Marco-baptista
Brianm-culley
Richardg-fessler
Jack-allen
Steven-kirshblum
Joseph-pantginis

Lineage Announces Changes to Board of Directors

Lineage Cell Therapeutics, Inc. is saddened to report the passing of its long-serving Chairman of the Board of Directors, Mr. Alfred D. Kingsley, and offers its deepest condolences to Mr....

California
United-states
American
Michaelh-mulroy
Alfredd-kingsley
Los-angeles
Financial-strategy-committee
Senior-advisor-to-camberview-partners
Audit-committee
Company-board-of-directors
Strategic-affairs
Genentech

BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA) Head to Head Comparison

BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA) Head to Head Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Vancouver
British-columbia
Canada
Charlesl-wiseman
Isaacb-maresky
Brooklyn-immunotherapeutics-inc

Head-To-Head Survey: Eterna Therapeutics (NASDAQ:ERNA) & BriaCell Therapeutics (OTCMKTS:BCTXF)

Head-To-Head Survey: Eterna Therapeutics (NASDAQ:ERNA) & BriaCell Therapeutics (OTCMKTS:BCTXF)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Vancouver
British-columbia
Canada
Cambridge
Cambridgeshire
United-kingdom
Massachusetts
United-states
Charlesl-wiseman
Isaacb-maresky
Eterna-therapeutics-inc

Latest Breaking News On - Eterna therapeutics - Page 1 : vimarsana.com

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium (&quot;2nd SCIIS&quot;). The 2nd SCIIS aims...

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases...

Award Will Support 2nd Annual Spinal Cord Injury Investor Symposium To Be Held June 26 and 27, 2024 ...

Lineage Cell Therapeutics, Inc. is saddened to report the passing of its long-serving Chairman of the Board of Directors, Mr. Alfred D. Kingsley, and offers its deepest condolences to Mr....

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS"). The 2nd SCIIS aims...